Answer
Respreeza is contraindicated in IgA-deficient patients with known antibodies against IgA because of the risk of severe hypersensitivity and anaphylactic reactions.
Sources for this answer
- RespreezaCSL Behring UK Limited · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked